Nope. It's not one or the other. The side that expects k to be a stand alone therapy also expects that it may be used in combination. Both are possible depending on the type of cancer and results of the trial(s).
"Our research to date has shown the potential of Kevetrin™ as a stand-alone therapy." - Dr. Menon
In response to:
shenanigan Wednesday, 10/01/14 08:25:25 AM Re: None Post # of 72026 Not a bad argument for CTIX shareholders.
K will be a multi billion dollar COMBO drug stated by some while the other side says K will be a multi billion dollar STAND ALONE drug. Either way it will benefit many in need of help and also set many families financially. Have a great day.
As always, in my opinion only. Do your own due diligence!